KEGG   DRUG: Pivekimab
Entry
D12307                      Drug                                   
Name
Pivekimab (USAN)
Formula
C6476H10034N1720O2031S46
Exact mass
145866.1905
Mol weight
145956.34
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYIFT SSIMHWVRQA PGQGLEWIGY IKPYNDGTKY
NEKFKGRATL TSDRSTSTAY MELSSLRSED TAVYYCAREG GNDYYDTMDY WGQGTLVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD
ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
WQQGNVFSCS VMHEALHNHY TQKSLCLSPG
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRASQDIN SYLSWFQQKP GKAPKTLIYR VNRLVDGVPS
RFSGSGSGND YTLTISSLQP EDFATYYCLQ YDAFPYTFGQ GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H148-H204, H224-L214, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'96, H'148-H'204, H'224-L'214, H'265-H'325, H'371-H'429, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplastiv, Anti-IL3 receptor antibody
  Type
Monoclonal antibody
Target
IL3RA (CD123) [HSA:3563] [KO:K04737]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04151  PI3K-Akt signaling pathway
hsa04630  JAK-STAT signaling pathway
hsa04640  Hematopoietic cell lineage
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    IL3RA (CD123)
     D12307  Pivekimab (USAN)
Other DBs
CAS: 2234335-84-1
PubChem: 497620720
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system